Myriad Genetics pulls sales forecast as coronavirus disrupts operations

Myriad Genetics, one of the largest genetic testing companies, has retracted its sales forecasts for its 2020 fiscal year, citing disruptions to its business as a result of the COVID-19 pandemic.